; onclick=)
Notice (8): Undefined index: api_key [APP/Controller/PageprocessController.php, line 111]Notice (8): Undefined index: site_id [APP/Controller/PageprocessController.php, line 112]/wp-content/uploads/2023/06/atrophic-variation-of-scleroderma_252595.jpg?fit=800%2C600&ssl=1" class="aligncenter wp-post-image" alt="" decoding="async" srcset="https://i0.wp.com/
Notice (8): Undefined index: api_key [APP/Controller/PageprocessController.php, line 111]
Notice (8): Undefined index: site_id [APP/Controller/PageprocessController.php, line 112]/wp-content/uploads/2023/06/atrophic-variation-of-scleroderma_252595.jpg?w=800&ssl=1 800w, https://i0.wp.com/
Notice (8): Undefined index: api_key [APP/Controller/PageprocessController.php, line 111]
Notice (8): Undefined index: site_id [APP/Controller/PageprocessController.php, line 112]/wp-content/uploads/2023/06/atrophic-variation-of-scleroderma_252595.jpg?resize=768%2C576&ssl=1 768w, https://i0.wp.com/
Notice (8): Undefined index: api_key [APP/Controller/PageprocessController.php, line 111]
Notice (8): Undefined index: site_id [APP/Controller/PageprocessController.php, line 112]/wp-content/uploads/2023/06/atrophic-variation-of-scleroderma_252595.jpg?resize=360%2C270&ssl=1 360w, https://i0.wp.com/
Notice (8): Undefined index: api_key [APP/Controller/PageprocessController.php, line 111]
Notice (8): Undefined index: site_id [APP/Controller/PageprocessController.php, line 112]/wp-content/uploads/2023/06/atrophic-variation-of-scleroderma_252595.jpg?resize=600%2C450&ssl=1 600w" sizes="(max-width: 800px) 100vw, 800px" data-attachment-id="254819" data-permalink="https://rxharun.com/rxharun/rx-dermatology-a-z/atrophic-variation-of-scleroderma/attachment/atrophic-variation-of-scleroderma-2/" data-orig-file="https://i0.wp.com/
Notice (8): Undefined index: api_key [APP/Controller/PageprocessController.php, line 111]
Notice (8): Undefined index: site_id [APP/Controller/PageprocessController.php, line 112]/wp-content/uploads/2023/06/atrophic-variation-of-scleroderma_252595.jpg?fit=800%2C600&ssl=1" data-orig-size="800,600" data-comments-opened="0" data-image-meta="{"aperture":"0","credit":"","camera":"","caption":"","created_timestamp":"0","copyright":"","focal_length":"0","iso":"0","shutter_speed":"0","title":"","orientation":"0"}" data-image-title="Atrophic Variation of Scleroderma" data-image-description="" data-image-caption="" data-medium-file="https://i0.wp.com/
Notice (8): Undefined index: api_key [APP/Controller/PageprocessController.php, line 111]
Notice (8): Undefined index: site_id [APP/Controller/PageprocessController.php, line 112]/wp-content/uploads/2023/06/atrophic-variation-of-scleroderma_252595.jpg?fit=800%2C600&ssl=1" data-large-file="https://i0.wp.com/
Notice (8): Undefined index: api_key [APP/Controller/PageprocessController.php, line 111]
Notice (8): Undefined index: site_id [APP/Controller/PageprocessController.php, line 112]/wp-content/uploads/2023/06/atrophic-variation-of-scleroderma_252595.jpg?fit=800%2C600&ssl=1" data-jpibfi-post-excerpt="" data-jpibfi-post-url="https://rxharun.com/rxharun/rx-dermatology-a-z/atrophic-variation-of-scleroderma/" data-jpibfi-post-title="Atrophic Variation of Scleroderma" data-jpibfi-src="https://i0.wp.com/
Notice (8): Undefined index: api_key [APP/Controller/PageprocessController.php, line 111]
Notice (8): Undefined index: site_id [APP/Controller/PageprocessController.php, line 112]/wp-content/uploads/2023/06/atrophic-variation-of-scleroderma_252595.jpg?fit=800%2C600&ssl=1">
Atrophic variation of scleroderma, also known as scleroderma atrophicans, is a rare form of scleroderma that is characterized by thinning and loss of skin tissue. The condition can cause skin to become tight, shiny, and translucent, with visible blood vessels and a wrinkled appearance. Atrophic scleroderma can affect different parts of the body, including the face, limbs, and trunk. There is no cure for atrophic scleroderma, but there are several treatments that can help manage the symptoms and slow the progression of the disease.
Scleroderma is an autoimmune disease that affects the connective tissue in the body. The disease is characterized by thickening and hardening of the skin and other tissues, as well as the formation of scar tissue. There are two main types of scleroderma: localized and systemic. Localized scleroderma primarily affects the skin and underlying tissues, while systemic scleroderma affects multiple organ systems. Within the spectrum of scleroderma, there is a subtype known as atrophic scleroderma, which is characterized by thinning of the skin and underlying tissues. This subtype is relatively rare, and its clinical manifestations can vary widely. In this article, we will provide a detailed overview of atrophic scleroderma, including its definitions and various subtypes.
- Definition of Atrophic Scleroderma
Atrophic scleroderma is a subtype of scleroderma that is characterized by thinning of the skin and underlying tissues. This thinning can occur in various parts of the body, including the face, arms, legs, and trunk. Atrophic scleroderma is a relatively rare form of the disease, and its clinical manifestations can vary widely.
- Types of Atrophic Scleroderma
There are several subtypes of atrophic scleroderma, each of which is characterized by unique clinical features. These subtypes include:
a. Acrosclerosis
Acrosclerosis is a type of atrophic scleroderma that primarily affects the fingers and toes. This subtype is characterized by thinning of the skin on the fingers and toes, which can lead to ulceration and tissue loss. Acrosclerosis can also cause the nails to become brittle and distorted, and can lead to the formation of small, painful nodules.
b. Facial atrophy
Facial atrophy is a subtype of atrophic scleroderma that affects the face. This subtype is characterized by thinning of the skin and underlying tissues, which can lead to a sunken appearance of the cheeks, temples, and forehead. Facial atrophy can also cause the eyes to appear more prominent, and can lead to thinning of the lips.
c. Generalized atrophy
Generalized atrophy is a type of atrophic scleroderma that affects multiple areas of the body. This subtype is characterized by thinning of the skin and underlying tissues, which can lead to a generalized wasting of the body. Generalized atrophy can also cause joint pain and stiffness, as well as muscle weakness.
d. Linear atrophy
Linear atrophy is a subtype of atrophic scleroderma that follows a linear pattern along the skin. This subtype is characterized by thinning of the skin and underlying tissues, which can lead to a linear depression in the skin. Linear atrophy can also cause a loss of hair in the affected area.
Causes
Atrophic variation is a subtype of localized scleroderma characterized by thinning of the skin, loss of subcutaneous tissue, and a depressed appearance of the affected area. There are various causes of atrophic variation in scleroderma, and we will discuss them in detail below.
- Linear scleroderma: Linear scleroderma is a subtype of localized scleroderma that affects a specific area of the body in a linear or band-like pattern. It can cause atrophy of the affected skin and subcutaneous tissue.
- Morphea: Morphea is another subtype of localized scleroderma characterized by oval or circular patches of thickened, hardened skin that can lead to atrophy.
- Lichen sclerosis: Lichen sclerosis is a chronic inflammatory skin condition that can cause atrophy of the vulva, penis, or anus.
- Trauma: Trauma to the skin can cause scarring and atrophy in scleroderma patients. This is especially true for those with localized scleroderma.
- Inflammation: Inflammation is a key driver of atrophic variation in scleroderma. Chronic inflammation leads to the destruction of the underlying tissue and can result in the loss of skin and fat in affected areas.
- Vascular damage: Vascular damage, particularly damage to small blood vessels, can result in the loss of blood flow to affected areas, leading to tissue death and atrophy.
- Fibrosis: Fibrosis, or the excessive accumulation of collagen and other proteins, can lead to tissue scarring and atrophy in scleroderma.
- Autoimmunity: Scleroderma is an autoimmune disease, meaning that the immune system mistakenly attacks healthy tissue in the body. This can lead to tissue damage and atrophy.
- Genetics: Some forms of scleroderma are believed to have a genetic component, which may make certain individuals more susceptible to the disease and its complications.
- Hormonal imbalances: Hormonal imbalances, particularly imbalances in estrogen and progesterone, may play a role in the development of atrophic variation in scleroderma.
- Age: Older individuals may be more susceptible to the development of atrophic variation in scleroderma, as the aging process can lead to a decrease in the production of collagen and other important proteins.
- Nutritional deficiencies: Nutritional deficiencies, particularly deficiencies in vitamins and minerals such as vitamin D, may contribute to the development of atrophic variation in scleroderma.
- Environmental factors: Environmental factors such as exposure to toxins or pollutants may increase the risk of developing atrophic variation in scleroderma.
- Infectious agents: Some studies suggest that infectious agents, such as certain viruses or bacteria, may play a role in the development of scleroderma and its complications.
- Radiation therapy: Radiation therapy, which is used to treat certain types of cancer, may lead to the development of atrophic variation in the skin and other tissues.
- Medications: Some medications, particularly chemotherapy drugs and certain antibiotics, may contribute to the development of atrophic variation in scleroderma.
- Smoking: Smoking is a known risk factor for the development of scleroderma and may increase the risk of developing atrophic variation in affected areas.
- Alcohol consumption: Heavy alcohol consumption may contribute to the development of atrophic variation in scleroderma by damaging the liver and other organs.
- Stress: Chronic stress may exacerbate the symptoms of scleroderma and may contribute to the development of atrophic variation in affected areas.
- Hormonal therapy: Hormonal therapy, particularly in women undergoing menopause, may contribute to the development of atrophic variation in scleroderma.
- Obesity: Obesity may increase the risk of developing atrophic variation in scleroderma, as excess body fat can contribute to inflammation and tissue damage.
- Infection: Certain infections such as Borrelia burgdorferi, the bacterium that causes Lyme disease, have been associated with atrophic variation in scleroderma patients.
- Medications: Certain medications such as long-term use of systemic corticosteroids can cause atrophy of the skin and subcutaneous tissue.
- Radiation therapy: Radiation therapy for cancer treatment can cause atrophy of the skin and subcutaneous tissue in the affected area.
- Nutritional deficiencies: Nutritional deficiencies, particularly vitamin B12 deficiency, can cause atrophy of the skin and subcutaneous tissue in scleroderma patients.
- Autoimmune thyroid disease: Autoimmune thyroid disease such as Hashimoto’s thyroiditis has been associated with atrophic variation in scleroderma patients.
- Diabetes: Diabetes can cause atrophy of the skin and subcutaneous tissue in scleroderma patients.
- Chronic kidney disease: Chronic kidney disease can cause atrophy of the skin and subcutaneous tissue in scleroderma patients.
- Genetics: Genetic factors have been implicated in the development of scleroderma and atrophic variation.
- Hormonal imbalances: Hormonal imbalances, particularly in women, have been associated with atrophic variation in scleroderma patients.
- Environmental factors: Environmental factors such as exposure to certain chemicals or toxins may contribute to the development of scleroderma and atrophic variation.
- Inflammatory bowel disease: Inflammatory bowel disease such as Crohn’s disease or ulcerative colitis has been associated with atrophic variation in scleroderma patients.
- Systemic lupus erythematosus: Systemic lupus erythematosus (SLE) is another autoimmune disorder that can cause atrophy of the skin and subcutaneous tissue.
- Rheumatoid arthritis: Rheumatoid arthritis is a chronic autoimmune disorder that can lead to atrophy of the skin and subcutaneous tissue in some patients.
Symptoms
Symptoms of atrophic scleroderma in detail.
- Skin Changes: Atrophic scleroderma can cause a range of skin changes, including thinning, dryness, and scaling. The skin may also appear shiny and tight, and may be more sensitive to the touch.
- Raynaud’s Phenomenon: Raynaud’s phenomenon is a common symptom of scleroderma, including atrophic scleroderma. It is characterized by changes in the color of the skin in response to cold or stress. The affected area may turn white, blue, or red, and may feel numb or tingly.
- Joint Pain: Atrophic scleroderma can cause joint pain and stiffness, which can be particularly severe in the morning or after periods of inactivity.
- Muscle Weakness: Muscle weakness is a common symptom of scleroderma, including atrophic scleroderma. It can make it difficult to perform everyday tasks and may be accompanied by fatigue.
- Gastrointestinal Symptoms: Atrophic scleroderma can cause a range of gastrointestinal symptoms, including acid reflux, bloating, constipation, and diarrhea.
- Shortness of Breath: Atrophic scleroderma can cause shortness of breath and chest pain, which may be a sign of lung involvement.
- Dry Eyes: Atrophic scleroderma can cause dry eyes, which can be uncomfortable and may lead to vision problems.
- Dry Mouth: Atrophic scleroderma can cause dry mouth, which can lead to difficulties with chewing, swallowing, and speaking.
- Nail Changes: Atrophic scleroderma can cause changes in the nails, including thinning, brittleness, and ridges.
- Fatigue: Fatigue is a common symptom of scleroderma, including atrophic scleroderma. It can make it difficult to perform everyday tasks and may be accompanied by muscle weakness.
- Hair Loss: Atrophic scleroderma can cause hair loss, particularly in the affected areas of the scalp.
- Photosensitivity: Atrophic scleroderma can cause sensitivity to sunlight, which can lead to skin rashes and other symptoms.
- Mouth Ulcers: Atrophic scleroderma can cause mouth ulcers, which can be painful and may make it difficult to eat and drink.
- Swelling: Atrophic scleroderma can cause swelling in the affected areas, particularly in the hands and feet.
- Telangiectasia: Telangiectasia is a common symptom of scleroderma, including atrophic scleroderma. It is characterized by the appearance of small, red, spider-like blood vessels on the skin.
- Heartburn: Atrophic scleroderma can cause heartburn and other symptoms of acid reflux, which can be uncomfortable and may lead to complications.
- Abnormal Heart Rhythms: Atrophic scleroderma can cause abnormal heart rhythms, which may be a sign of heart involvement.
Diagnosis
Diagnoses and tests for atrophic scleroderma, along with explanations of each.
- Clinical examination: A thorough physical examination by a healthcare provider can help diagnose atrophic scleroderma. The provider may examine the skin, joints, and other organs to check for signs and symptoms of the disease.
- Biopsy: A small sample of skin may be removed and examined under a microscope to confirm the diagnosis of atrophic scleroderma. The biopsy can also rule out other skin conditions that may have similar symptoms.
- Skin thickness measurement: A healthcare provider may use a special device called a skin thickness meter to measure the thickness of the skin at various points on the body. This can help monitor the progression of the disease over time.
- Blood tests: Blood tests may be done to check for specific antibodies associated with scleroderma. These tests can also help identify other underlying medical conditions that may be contributing to the symptoms.
- Imaging studies: Imaging studies, such as X-rays, CT scans, and MRI scans, may be done to check for changes in internal organs that can occur with scleroderma.
- Pulmonary function tests: These tests measure lung function and can help identify pulmonary complications associated with scleroderma, such as pulmonary fibrosis.
- Echocardiogram: An echocardiogram is a non-invasive test that uses sound waves to create images of the heart. This test can help identify any heart problems associated with scleroderma.
- Electrocardiogram (ECG): An ECG is a test that records the electrical activity of the heart. It can help identify any abnormal heart rhythms that may be present in patients with scleroderma.
- Capillaroscopy: This test uses a special microscope to examine the small blood vessels in the fingers and toes. Changes in these vessels can be a sign of scleroderma.
- Nailfold videocapillaroscopy: This is a specialized type of capillaroscopy that uses a video camera to capture images of the nailfold blood vessels. This test can help identify early changes associated with scleroderma.
- Esophageal motility studies: These tests measure the movement of food through the esophagus and can help identify any swallowing difficulties associated with scleroderma.
- Gastrointestinal imaging: Imaging studies, such as CT scans or barium swallow tests, may be done to check for damage to the gastrointestinal tract.
- Serum creatinine: This blood test measures the level of creatinine in the blood, which can help identify any kidney damage associated with scleroderma.
- Urinalysis: A urine test can help identify any kidney problems associated with scleroderma, such as protein in the urine.
- Rheumatoid factor: This blood test measures the level of rheumatoid factor in the blood, which can be elevated in patients with scleroderma.
- Anti-nuclear antibody (ANA) test: This blood test checks for the presence of antibodies that attack the nucleus of cells. ANA levels are often elevated in patients with scleroderma.
Treatment
treatments for atrophic variation of scleroderma, explained in detail.
- Topical steroids: Topical steroids are commonly used to treat atrophic scleroderma. They work by reducing inflammation and swelling in the affected areas, which can help improve skin texture and appearance.
- Topical calcipotriol: Calcipotriol is a type of vitamin D that is used to treat psoriasis and other skin conditions. It has been found to be effective in treating atrophic scleroderma by promoting skin cell growth and reducing inflammation.
- Topical tacrolimus: Tacrolimus is an immunosuppressant drug that is used to treat eczema and other skin conditions. It has been found to be effective in treating atrophic scleroderma by reducing inflammation and promoting skin cell growth.
- Topical retinoids: Retinoids are derived from vitamin A and are commonly used to treat acne and other skin conditions. They have been found to be effective in treating atrophic scleroderma by promoting collagen synthesis and reducing skin thinning.
- Moisturizers: Moisturizers can help keep the skin hydrated and reduce dryness and cracking, which can help improve skin texture and appearance.
- Sunscreen: Sunscreen can help protect the skin from the harmful effects of UV radiation, which can worsen atrophic scleroderma.
- Physical therapy: Physical therapy can help improve joint mobility and muscle strength, which can help reduce the risk of complications and improve quality of life.
- Occupational therapy: Occupational therapy can help improve daily living skills and reduce the risk of complications, such as pressure ulcers.
- Splints: Splints can help support the joints and improve mobility, which can help reduce the risk of complications and improve quality of life.
- Wound care: Wound care is important for preventing infection and promoting healing in areas of skin damage, such as ulcers.
- Antihistamines: Antihistamines can help reduce itching and inflammation, which can help improve skin texture and appearance.
- Nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs can help reduce pain and inflammation, which can help improve quality of life.
- Immunosuppressant drugs: Immunosuppressant drugs can help reduce inflammation and slow the progression of atrophic scleroderma.
- Methotrexate: Methotrexate is an immunosuppressant drug that is commonly used to treat rheumatoid arthritis and other autoimmune diseases. It has been found to be effective in treating atrophic scleroderma by reducing inflammation and promoting skin cell growth.
- Cyclophosphamide: Cyclophosphamide is a chemotherapy drug that is sometimes used to treat atrophic scleroderma. It works by suppressing the immune system and reducing inflammation.
- Mycophenolate mofetil: Mycophenolate mofetil is an immunosuppressant drug that is commonly used to prevent rejection in organ transplant recipients. It has been found to be effective in treating atrophic scleroderma by reducing
- Immunosuppressants: Immunosuppressants are medications that suppress the immune system’s response to help manage the inflammation associated with atrophic scleroderma. These medications can help slow the progression of the disease and reduce the risk of complications.
- Phototherapy: Phototherapy involves exposing the skin to ultraviolet light to help reduce inflammation and improve the appearance of the skin. This treatment is often used in combination with other therapies to manage atrophic scleroderma.
- Moisturizers: Moisturizers can help keep the skin hydrated and reduce the appearance of dryness and cracking associated with atrophic scleroderma.
- Topical calcineurin inhibitors: Topical calcineurin inhibitors are medications that can help reduce inflammation and improve the appearance of the skin. These medications are often used as an alternative to topical corticosteroids.
- Anti-inflammatory medications: Anti-inflammatory medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), can help reduce inflammation and manage pain associated with atrophic scleroderma.
- Physical therapy: Physical therapy can help improve mobility and reduce the risk of joint stiffness associated with atrophic scleroderma. A physical therapist can provide exercises and stretches to help manage the symptoms of the disease.
- Occupational therapy: Occupational therapy can help individuals with atrophic scleroderma learn how to manage their daily activities while minimizing the impact of the disease.
- Surgery: Surgery may be recommended to remove damaged tissue or repair joint damage associated with atrophic scleroderma.
- Stem cell transplantation: Stem cell transplantation is an experimental treatment that involves transplanting stem cells to help regenerate damaged tissue and reduce inflammation associated with atrophic scleroderma.
- Intravenous immunoglobulin: Intravenous immunoglobulin is a medication that can help manage the immune system’s response to reduce inflammation associated with atrophic scleroderma.
- Plasma exchange: Plasma exchange is a treatment that involves removing and replacing the plasma in the blood to help manage the immune system’s response and reduce inflammation associated with atrophic scleroderma.
- Biologic medications: Biologic medications are medications that target specific proteins involved in the immune system’s response. These medications can help reduce inflammation and manage the symptoms of atrophic scleroderma.
- N-acetylcysteine: N-acetylcysteine is a medication that can help reduce inflammation and improve the skin’s appearance in individuals with atrophic scleroderma.
- Antioxidants: Antioxidants, such as vitamin E and selenium, can help reduce inflammation and improve the skin’s appearance in individuals with atrophic scleroderma.
- Omega-3 fatty acids: Omega-3 fatty acids can help reduce inflammation and improve the skin’s appearance in individuals with atrophic scleroderma.
References
